BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 21087892)

  • 21. Progress in oral personalized medicine: contribution of 'omics'.
    Glurich I; Acharya A; Brilliant MH; Shukla SK
    J Oral Microbiol; 2015; 7():28223. PubMed ID: 26344171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A computational framework to integrate high-throughput '-omics' datasets for the identification of potential mechanistic links.
    Pedersen HK; Forslund SK; Gudmundsdottir V; Petersen AØ; Hildebrand F; Hyötyläinen T; Nielsen T; Hansen T; Bork P; Ehrlich SD; Brunak S; Oresic M; Pedersen O; Nielsen HB
    Nat Protoc; 2018 Dec; 13(12):2781-2800. PubMed ID: 30382244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A reinvigorated era of bacterial secondary metabolite discovery.
    Sidebottom AM; Carlson EE
    Curr Opin Chem Biol; 2015 Feb; 24():104-11. PubMed ID: 25461728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploration of the Biosynthetic Potential of the
    Blair PM; Land ML; Piatek MJ; Jacobson DA; Lu TS; Doktycz MJ; Pelletier DA
    mSystems; 2018; 3(5):. PubMed ID: 30320216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current advances in microbiome sciences within the US Department of Defense: part 2 - enabling technologies and environmental microbiomes.
    Colston SM; Barbato RA; Goodson MS; Karl JP; Kokoska RJ; Leary DD; Racicot K; Varaljay V; Soares JW
    BMJ Mil Health; 2023 Jun; ():. PubMed ID: 37336582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What did we learn from 'omics' studies in osteoarthritis.
    Ruiz-Romero C; Rego-Perez I; Blanco FJ
    Curr Opin Rheumatol; 2018 Jan; 30(1):114-120. PubMed ID: 29035928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrating Systems and Synthetic Biology to Understand and Engineer Microbiomes.
    Leggieri PA; Liu Y; Hayes M; Connors B; Seppälä S; O'Malley MA; Venturelli OS
    Annu Rev Biomed Eng; 2021 Jul; 23():169-201. PubMed ID: 33781078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Help, there are 'omics' in my comparative physiology!
    Torson AS; Dong YW; Sinclair BJ
    J Exp Biol; 2020 Dec; 223(Pt 24):. PubMed ID: 33334947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential natural product discovery from microbes through a diversity-guided computational framework.
    Pacharawongsakda E; Yokwai S; Ingsriswang S
    Appl Microbiol Biotechnol; 2009 Mar; 82(3):579-86. PubMed ID: 19148634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative Analyses of Vertebrate Gut Microbiomes Reveal Convergence between Birds and Bats.
    Song SJ; Sanders JG; Delsuc F; Metcalf J; Amato K; Taylor MW; Mazel F; Lutz HL; Winker K; Graves GR; Humphrey G; Gilbert JA; Hackett SJ; White KP; Skeen HR; Kurtis SM; Withrow J; Braile T; Miller M; McCracken KG; Maley JM; Ezenwa VO; Williams A; Blanton JM; McKenzie VJ; Knight R
    mBio; 2020 Jan; 11(1):. PubMed ID: 31911491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Foodomics as part of the host-microbiota-exposome interplay.
    Putignani L; Dallapiccola B
    J Proteomics; 2016 Sep; 147():3-20. PubMed ID: 27130534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Linking Biosynthetic Gene Clusters to their Metabolites via Pathway- Targeted Molecular Networking.
    Trautman EP; Crawford JM
    Curr Top Med Chem; 2016; 16(15):1705-16. PubMed ID: 26456470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Computational Genomics of Specialized Metabolism: from Natural Product Discovery to Microbiome Ecology.
    Medema MH
    mSystems; 2018; 3(2):. PubMed ID: 29556550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Virtual Metabolic Human database: integrating human and gut microbiome metabolism with nutrition and disease.
    Noronha A; Modamio J; Jarosz Y; Guerard E; Sompairac N; Preciat G; Daníelsdóttir AD; Krecke M; Merten D; Haraldsdóttir HS; Heinken A; Heirendt L; Magnúsdóttir S; Ravcheev DA; Sahoo S; Gawron P; Friscioni L; Garcia B; Prendergast M; Puente A; Rodrigues M; Roy A; Rouquaya M; Wiltgen L; Žagare A; John E; Krueger M; Kuperstein I; Zinovyev A; Schneider R; Fleming RMT; Thiele I
    Nucleic Acids Res; 2019 Jan; 47(D1):D614-D624. PubMed ID: 30371894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolite induction via microorganism co-culture: a potential way to enhance chemical diversity for drug discovery.
    Bertrand S; Bohni N; Schnee S; Schumpp O; Gindro K; Wolfender JL
    Biotechnol Adv; 2014 Nov; 32(6):1180-204. PubMed ID: 24651031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using natural products for drug discovery: the impact of the genomics era.
    Zhang MM; Qiao Y; Ang EL; Zhao H
    Expert Opin Drug Discov; 2017 May; 12(5):475-487. PubMed ID: 28277838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integration of 'omics' data: does it lead to new insights into host-microbe interactions?
    Kint G; Fierro C; Marchal K; Vanderleyden J; De Keersmaecker SC
    Future Microbiol; 2010 Feb; 5(2):313-28. PubMed ID: 20143952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Second Era of OMICS in Caries Research: Moving Past the Phase of Disillusionment.
    Nascimento MM; Zaura E; Mira A; Takahashi N; Ten Cate JM
    J Dent Res; 2017 Jul; 96(7):733-740. PubMed ID: 28384412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A metagenomic insight into our gut's microbiome.
    Lepage P; Leclerc MC; Joossens M; Mondot S; Blottière HM; Raes J; Ehrlich D; Doré J
    Gut; 2013 Jan; 62(1):146-58. PubMed ID: 22525886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjusting for age improves identification of gut microbiome alterations in multiple diseases.
    Ghosh TS; Das M; Jeffery IB; O'Toole PW
    Elife; 2020 Mar; 9():. PubMed ID: 32159510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.